-
Mashup Score: 0Heavily Pretreated Patients With Richter Syndrome Achieved Antitumor Activity With Glofitamab - 10 month(s) ago
Glofitamab monotherapy led to a 63.6% overall response rate in heavily pretreated patients with Richter syndrome.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Dose-Dense and Dose-Intense ABVD Is Linked To Improved PFS in Frontline Treatment of Advanced Classical Hodgkin Lymphoma - 10 month(s) ago
Intensified doxorubicin, bleomycin, vinblastine, dacarbazine, and granulocyte colony–stimulating factor (ABVD) was associated with a 56% reduction in the relative risk of 3-year progression, relapse, or death.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0NCCN Guideline Update Outlines Best Practices With High-Dose Methotrexate, Glucarpidase in Patients With ALL/B-Cell Lymphoma - 10 month(s) ago
The National Comprehensive Cancer Network has updated their guidelines on high-dose methotrexate and glucarpidase.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Most Older Patients Report Functional Recovery Following Colorectal Cancer Surgery - 10 month(s) ago
By 3 months postsurgery, most older patients with colon or rectal cancer had achieved functional recovery.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials - 10 month(s) ago
Jacki Garcia, RN, BSN, CNRN; and Kristen Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Ready-to-Dilute Cyclophosphamide Injections Obtain FDA Approval - 10 month(s) ago
The FDA has approved a ready-to-dilute cyclophosphamide injection.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Patient-Centric Infusions Promote Patient Autonomy and Strengthen Nurse-Patient Relationships - 10 month(s) ago
Arletta Jackson, RN, MSN, explains the concept of patient-centric infusion and how it benefits both nurses and patients.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Long-Term Assessments Show Similar PRO Outcomes With Radiotherapy Vs Surgery for Patients With OPSCC - 10 month(s) ago
Patients with oropharyngeal squamous cell carcinoma who received primary radiotherapy or surgery demonstrated similar long-term patient-reported outcomes.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Heavily Pretreated Patients With Richter Syndrome Achieved Antitumor Activity With Glofitamab - 10 month(s) ago
Glofitamab monotherapy led to a 63.6% overall response rate in heavily pretreated patients with Richter syndrome.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
On-pathway regimens are associated with lower costs, and slightly higher emergency department visits and adverse event rates in cancer care.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Glofitamab monotherapy led to a 63.6% overall response rate in heavily pretreated patients with Richter syndrome. #oncology #nursing #RichtersSyndrome https://t.co/vrbs1S74ZB